FDA sends letter to Novo Nordisk over potential GLP-1 side effects
The U.S. Food and Drug Administration sent a warning letter this month to Novo Nordisk, the maker of…
FDA sends letter to Novo Nordisk over potential GLP-1 side effects
The U.S. Food and Drug Administration sent a warning letter this month to Novo Nordisk, the maker of…
Hims & Hers abandons plan for cheaper Wegovy knockoff after FDA warning
Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy…